Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse

Genome Research

Volumn 12, Issue 5, 2002, Pages 713-728

  Bi, Weimin ^a   Yan, Jiong ^b   Stankiewicz, Pawe ^b   Park, Sung Sup ^c   Walz, Katherina ^c   Boerkoel, Cornelius F ^d   Potocki, Lorraine ^d   Shaffer, Lisa G ^d   Devriendt, Koen ^d   Nowaczyk, Magorzata J M ^e   Inoue, Ken ^e   Lupski, James R ^f  

^a Departments of Molecular and Human Genetics   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e MCMASTER UNIVERSITY   (Canada)

^f Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONTIG;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BEHAVIOR DISORDER; CHILD; CHROMOSOME 11; CHROMOSOME 17P; CHROMOSOME DELETION; COMPARATIVE GENE MAPPING; CONGENITAL MALFORMATION; CONTROLLED STUDY; DNA TRANSPOSITION; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE ORDER; GENE STRUCTURE; GENETIC CONSERVATION; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENOME ANALYSIS; HUMAN; MALE; MENTAL DEFICIENCY; MOLECULAR EVOLUTION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SLEEP DISORDER; SMITH MAGENIS SYNDROME; SYNTENY; UNINDEXED SEQUENCE;

ABNORMALITIES, MULTIPLE; ANIMALS; CHAPERONINS; CHROMOSOME DELETION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CHROMOSOMES, ARTIFICIAL, P1 BACTERIOPHAGE; CHROMOSOMES, HUMAN, PAIR 17; CONTIG MAPPING; FEMALE; FUNGAL PROTEINS; GENE ORDER; HUMANS; MALE; MENTAL RETARDATION; MICE; PHYSICAL CHROMOSOME MAPPING; PROTON-TRANSLOCATING ATPASES; PSEUDOGENES; SACCHAROMYCES CEREVISIAE PROTEINS; SYNDROME; SYNTENY;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0036099554     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.73702     Document Type: Article

References (76)

1. Comparative genomic sequencing reveals a strikingly similar architecture of a conserved syntenic region on human chromosome 11p15.3 (including gene ST5) and mouse chromosome 7
2. Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6
3. 52) is composed primarily of processed pseudogenes
4. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution
5. An anchored framework BAC map of mouse chromosome 11 assembled using multiplex oligonucleotide hybridization
6. Genomic structure, evolution, and expression of human FLII, a gelsolin and leucine-rich-repeat family member: Overlap with LLGL
7. Fliih, the murine homologue of the Drosophila melanogaster flightless I gene: Nucleotide sequence, chromosomal mapping and overlap with Llglh
8. The Smith-Magenis syndrome [del(17)p11.2]: Clinical review and molecular advances
9. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome
10. Relationship between Charcot-Marie-Tooth 1A and Smith-Magenis regions. snU3 may be a candidate gene for the Smith-Magenis syndrome
11. Syndromes with lissencephaly. I: Miller-Dieker and Norman-Roberts syndromes and isolated lissencephaly
12. The DNA sequence of human chromosome 22
13. Definition of the critical interval for Smith-Magenis syndrome
14. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome
15. Analysis of the Cat Eye Syndrome critical region in humans and the region of conserved synteny in mice: A search for candidate genes at or near the human chromosome 22 pericentromere
16. Overexpression of a truncated human topoisomerase III partially corrects multiple aspects of the ataxia-telangiectasia phenotype
17. Molecular cloning, characterization and alternative splicing of the human cytoplasmic serine hydroxymethyltransferase gene
18. Molecular analysis of the Smith-Magenis syndrome: A possible contiguous-gene syndrome associated with del(17)(p11.2)
19. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2)
20. The Chromosome 21 Mapping and Sequencing Consortium. 2000. The DNA sequence of human chromosome 21
21. Sonic hedgehog participates in craniofacial morphogenesis and is down-regulated by teratogenic doses of retinoic acid
22. Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality
23. Cloning of a retinoic acid-induced gene, GT1, in the embryonal carcinoma cell line P19: Neuron-specific expression in the mouse brain
24. The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes
25. Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients
26. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells
27. Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse
28. Human and rodent DNA sequence comparisons: A mosaic model of genomic evolution
29. The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2
30. Initial sequencing and analysis of the human genome
31. DRG represents a family of two-closely related GTP-binding proteins
32. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1
33. Mammalian DNA topoisomerase IIIα is essential in early embryogenesis
34. Characterization of the human and mouse unconventional myosin XV genes responsible for hereditary deafness DFNB3 and shaker 2
35. Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome
36. Lack of catalytic activity of a murine mRNA cytoplasmic serine hydroxymethyltransferase splice variant: Evidence against alternative splicing as a regulatory mechanism
37. VHS domain marks a group of proteins involved in endocytosis and vesicular trafficking
38. Genomic organisation of the ∼1.5 Mb Smith-Magenis syndrome critical interval: Transcription map, genomic contig, and candidate gene analysis
39. Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits
40. Charcot-Marie-Tooth polyneuropathy: Duplication, gene dosage, and genetic heterogeneity
41. What makes an mRNA anti-sense-itive?
42. Mutations in the human Jagged1 gene are responsible for Alagille syndrome
43. Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast
44. Retinoic acid-induced asymmetric craniofacial growth and cleft palate in the TO mouse fetus
45. Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: Unequal nonsister chromatid exchange during spermatogenesis
46. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis
47. Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs
48. The tumour-suppressor genes Igl and dlg regulate basal protein targeting in Drosophila neuroblasts
49. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
50. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation
51. Molecular mechanism for duplication 17p11.2: The homologous recombination reciprocal of the Smith-Magenis microdeletion
52. Correction of deafness in shaker-2 mice by an unconventional myosin in a BAC transgene
53. A physical map of the mouse shaker-2 region contains many of the genes commonly deleted in Smith-Magenis syndrome (del17p11.2p11.2)
54. The GGAs promote ARF-dependent recruitment of clathrin to the TGN
55. A deoxyribonucleotidase in mitochondria: Involvement in regulation of dNTP pools and possible link to genetic disease
56. Slit: An extracellular protein necessary for development of midline glia and commissural axon pathways contains both EGF and LRR domains
57. Contiguous gene syndromes: A component of recognizable syndromes
58. PipMaker: A web server for aligning two genomic DNA sequences
59. Isolation of a cDNA encoding mouse DNA topoisomerase III which is highly expressed at the mRNA level in the testis
60. Transcription mapping in a medulloblastoma breakpoint interval and Smith-Magenis syndrome candidate region: Identification of 53 transcriptional units and new candidate genes
61. RA11 is a novel polyglutamine encoding gene that is deleted in Smith-Magenis syndrome patients
62. Molecular cytogenetics of contiguous gene syndromes: Mechanisms and consequences of gene dosage imbalance
63. PDZ domains and the organization of supramolecular complexes
64. Structure, expression profile and alternative processing of the human phosphatidylethanolamine N-methyltransferase (PEMT) gene
65. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene
66. Interstitial deletion of (17)(p11.2p11.2) in nine patients
67. Genome architecture, rearrangements, and genomic disorders
68. Interstitial deletion of (17)(p11.2p11.2): Report of six additional patients with a new chromosome deletion syndrome
69. A mouse homologue of the Drosophila tumour-suppressor gene 1(2)gl controlled by Hox-C8 in vivo
70. Cloning, expression and characterization of a novel human Ras-related protein that is regulated by glucocorticoid hormone
71. Transcription factor GATA3 and the human HDR syndrome
72. The sequence of the human genome
73. Characterization of the murine phosphatidylethanolamine N-methyltransferase-2 gene
74. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3
75. Atp11p and Atp12p are assembly factors for the F1-ATPase in human mitochondria
76. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene